Should adenocarcinoma of the esophagogastric junction be classified as esophageal cancer? A comparative analysis according to the seventh AJCC TNM classification

Annals of Surgery

Volumn 255, Issue 5, 2012, Pages 908-915

  Suh, Yun Suhk ^a   Han, Dong Seok ^a   Kong, Seong Ho ^a   Lee, Hyuk Joon ^a   Kim, Young Tae ^a   Kim, Woo Ho ^a   Lee, Kuhn Uk ^a   Yang, Han Kwang ^a  

^a Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AJCC TNM CLASSIFICATION; CANCER STAGING; CANCER SURGERY; COMPARATIVE STUDY; DISEASE CLASSIFICATION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LOWER ESOPHAGUS SPHINCTER; LOWER ESOPHAGUS SPHINCTER ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SIEWERT CLASSIFICATION; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; AGED; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 84859927853     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31824beb95     Document Type: Review

References (44)

1. Devesa SS, Blot WJ, Fraumeni JF, Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83:2049-2053. (Pubitemid 28525384)
2. Botterweck AA, Schouten LJ, Volovics A, et al. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol. 2000;29:645.
3. MacDonald WC. Clinical and pathologic features of adenocarcinoma of the gastric cardia. Cancer. 1972;29:724-732.
4. Saito H, Fukumoto Y, Osaki T, et al. Distinct recurrence pattern and outcome of adenocarcinoma of the gastric cardia in comparison with carcinoma of other regions of the stomach. World J Surg. 2006;30:1864-1869. (Pubitemid 44455000)
5. Ohno S, Tomisaki S, Oiwa H, et al. Clinicopathologic characteristics and outcome of adenocarcinoma of the human gastric cardia in comparison with carcinoma of other regions of the stomach. J Am Coll Surg. 1995;180: 577-582.
6. Chung JW, Lee GH, Choi KS, et al. Unchanging trend of esophagogastric junction adenocarcinoma in Korea: experience at a single institution based on Siewert's classification. Dis Esophagus. 2009;22:676-681.
7. Kampschoer GH, Nakajima T, Van de Velde CJ. Changing patterns in gastric adenocarcinoma. Br J Surg. 1989;76:914-916. (Pubitemid 19233275)
8. Okabayashi T, Gotoda T, Kondo H, et al. Early carcinoma of the gastric cardia in Japan: is it different from that in the West? Cancer. 2000;89:2555-2259.
9. Kodera Y, Yamamura Y, Shimizu Y, et al. Adenocarcinoma of the gastroesophageal junction in Japan: relevance of Siewert's classification applied to 177 cases resected at a single institution. J Am Coll Surg. 1999;189: 594-601.
10. Hasegawa S,Yoshikawa T, Cho H, et al. Is adenocarcinoma of the esophagogastric junction different between Japan andWestern countries? The incidence and clinicopathological features at a Japanese high-volume cancer center. World J Surg. 2009;33:95-103.
11. Siewert JR, Holscher AH, Becker K, et al. Cardia cancer: attempt at a therapeutically relevant classification. Chirurg. 1987;58:25-32. (Pubitemid 17007476)
12. Siewert JR, Stein HJ. Carcinoma of the gastroesophageal junctionclassification, pathology and extent of resection. Dis Esophagus. 1996;9: 173-182. (Pubitemid 26264246)
13. Siewert JR, Feith M,Werner M, et al. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg. 2000;232:353-361.
14. Wijnhoven BP, Siersema PD, Hop WC, et al. Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Rotterdam Oesophageal Tumour Study Group. Br J Surg. 1999;86:529-535. (Pubitemid 29195053)
15. Steup WH, De Leyn P, Deneffe G, et al. Tumors of the esophagogastric Junction. Long-term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of pTNM classification. J Thorac Cardiovasc Surg. 1996;111:85-95 (Pubitemid 26035175)
16. Edge SB, Byrd DR, Compton CC, et al., eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2009.
17. Rice TW, Rusch VW, Ishwaran H, et al. Cancer of the esophagus and esophagogastric junction. Cancer. 2010;116:3763-3773.
18. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma-2nd English Edition. Gastric Cancer. 1998;1:10-24.
19. Lagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825-831. (Pubitemid 29142625)
20. Farrow DC, Vaughan TL, Sweeney C, et al. Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer. Cancer Causes Control. 2000;11:231-238. (Pubitemid 30182140)
21. Shaheen N, Ransohoff DF. Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: scientific review. JAMA. 2002;287:1972-1981. (Pubitemid 34326418)
22. Kim MA, Lee HS, Yang HK, et al. Clinicopathologic and protein expression differences between cardia carcinoma and noncardia carcinoma of the stomach. Cancer. 2005;103:1439-1446. (Pubitemid 40410741)
23. Tajima Y, Yamazaki K, Makino R, et al. Differences in the histological findings, phenotypic marker expressions and genetic alterations between adenocarcinoma of the gastric cardia and distal stomach. Br J Cancer. 2007;96: 631-638.
24. Nomura A, Stemmermann GN, Chyou PH, et al. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med. 1991;325:1132.
25. Yao JC, Tseng JF, Worah S, et al. Clinicopathologic behavior of gastric adenocarcinoma in Hispanic patients: analysis of a single institution's experience over 15 years. J Clin Oncol. 2005;23:3094-3103. (Pubitemid 46224133)
26. An C, Choi IS, Yao JC, et al. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma. Clin Cancer Res. 2005;11:656-663. (Pubitemid 40116892)
27. Chow WH, Blaser MJ, Blot WJ, et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res. 1998;58:588-590. (Pubitemid 28099460)
28. Wu AH, Crabtree JE, Bernstein L, et al. Role of Helicobacter pylori CagA +strains and risk of adenocarcinoma of the stomach and esophagus. Int J Cancer. 2003;103:815-821. (Pubitemid 36110240)
29. Siewert JR, Feith M. Adenocarcinoma of the esophagogastric junction: competition between Barrett and gastric cancer. J Am Coll Surg. 2007;205:S49-S53. (Pubitemid 47488916)
30. Siewert JR, Bottcher K, Stein HJ, et al. Problem of proximal third gastric carcinoma. World J Surg. 1995;19:523-531.
31. Sakaguchi T,Watanabe A, Sawada H, et al.Characteristics and clinical outcome of proximal-third gastric cancer. J Am Coll Surg. 1998;187:352-357. (Pubitemid 28467609)
32. Goldsmith HS, Akiyama H. A comparative study of Japanese and American gastric dimensions. Ann Surg. 1979;190:690-693. (Pubitemid 10214459)
33. Macdonald WC, Macdonald JB. Adenocarcinoma of the esophagus and/or gastric cardia. Cancer. 1987;60:1094-1098. (Pubitemid 17157226)
34. Husemann B. Cardia carcinoma considered as a distinct clinical entity. Br J Surg. 1989;76:136-139. (Pubitemid 19057007)
35. Rice T, Rusch V, Apperson-Hansen C, et al. Worldwide esophageal cancer collaboration. Dis Esophagus. 2009;22:1-8.
36. Ahn HS, Lee HJ, Hahn S, et al. Evaluation of the Seventh American Joint Committee on Cancer/International Union Against Cancer Classification of gastric adenocarcinoma in comparison with the sixth classification. Cancer. 2010;116:5592-5598.
37. Nakajima T. Gastric cancer treatment guidelines in Japan. Gastric Cancer. 2002;5:1-5. (Pubitemid 34496345)
38. Fein M, Fuchs KH, Ritter MP, et al. Application of the new classification for cancer of the cardia. Surgery. 1998;124:707-714. (Pubitemid 28463268)
39. Hulscher JB, van Sandick JW, de Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002;347:1662-1669. (Pubitemid 35340784)
40. Sasako M, Sano T, Yamamoto S, et al. Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol. 2006;7:644-651. (Pubitemid 44123569)
41. Omloo JM, Lagarde SM, Hulscher JB, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg. 2007;246:992-1000. (Pubitemid 350179188)
42. Cense HA, SloofGW,Klaase JM, et al. Lymphatic drainage routes of the gastric cardia visualized by lymphoscintigraphy. J Nucl Med. 2004;45:247-252. (Pubitemid 47618644)
43. Mueller JD, Stein HJ, Oyang T, et al. Frequency and clinical impact of lymph node micrometastasis and tumor cell microinvolvement in patients with adenocarcinoma of the esophagogastric junction. Cancer. 2000;89:1874-1882.
44. OttK,WeberWA, FinkU, et al. Fluorodeoxyglucose-positron emission tomography in adenocarcinomas of the distal esophagus and cardia. World J Surg. 2003;27:1035-1039. (Pubitemid 37186239)